DNMT1 and lung carcinoma: The role of miR-185 has been investigated in various cancers including lung cancer, osteosarcoma and breast cancer by targeting SOX9, HK2, DNMT1 and E2F6, respectively (Tang et al., 2014; Lei et al., 2018; Liu et al., 2019).